Atossa Therapeutics
ATOS
11 hedge funds and large institutions have $1.04M invested in Atossa Therapeutics in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
4% less capital invested
Capital invested by funds: $1.08M → $1.04M (-$42.7K)
8% less funds holding
Funds holding: 12 → 11 (-1)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$62K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.82K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$87.4K |
| 2 |
Goldman Sachs
New York
|
-$39.5K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$8.46K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
ATOS Hedge Fund Activity: Q4 2014 in Review
11 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Atossa Therapeutics (ATOS) for Q4 2014, worth a combined $1.04M — down 3.9% from $1.08M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ATOS and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $62K. The largest seller was Virtu KCG Holdings, cutting an estimated $87.4K.
- 11 institutional investors held Atossa Therapeutics (ATOS) as of Q4 2014, down from 12 in Q3 2014.
- Funds reported $1.04M of Atossa Therapeutics stock for Q4 2014, down 3.9% quarter-over-quarter.
- 0 funds opened new Atossa Therapeutics positions in Q4 2014 and 1 closed out, a net change of -1 holder.
- The largest Atossa Therapeutics buyer in Q4 2014 was Vanguard Group, an estimated $62K added.
- The largest Atossa Therapeutics seller in Q4 2014 was Virtu KCG Holdings, an estimated $87.4K sold.
Based on aggregated 13F filings for Q4 2014.